These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20129189)

  • 21. Cushing's Disease Management: Glimpse Into 2051.
    Dalan R; Bornstein SR; Boehm BO
    Front Endocrinol (Lausanne); 2022; 13():943993. PubMed ID: 35872988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maximizing the accuracy of Inferior petrosal sinus sampling: validation of the use of Prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing's disease.
    Grant P; Dworakowska D; Carroll P
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):555-9. PubMed ID: 22017348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quo vadis, hypophysis? Some news and prospects].
    Marek J
    Vnitr Lek; 2007; 53(7-8):789-94. PubMed ID: 17915419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing's disease.
    Durcan E; Turan S; Sahin S; Sulu C; Taze SS; Kavla Y; Ozkaya HM; Kadioglu P
    Pituitary; 2021 Aug; 24(4):589-599. PubMed ID: 33665771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An approach to the evaluation and treatment of Cushing's disease.
    Brown RL; Weiss RE
    Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S37-46. PubMed ID: 17004856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary surgery and postoperative management in Cushing's disease.
    Utz AL; Swearingen B; Biller BM
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):459-78, xi. PubMed ID: 15850853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overnight dexamethasone suppression test in the diagnosis of Cushing's disease.
    Esfahanian F; Kazemi R
    Acta Med Iran; 2010; 48(4):222-5. PubMed ID: 21279933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Centered Outcomes with Pituitary and Parasellar Disease.
    Webb SM; Santos A; Aulinas A; Resmini E; Martel L; Martínez-Momblán MA; Valassi E
    Neuroendocrinology; 2020; 110(9-10):882-888. PubMed ID: 32101858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canadian consensus guidelines for the diagnosis and management of acromegaly.
    Ezzat S; Serri O; Chik CL; Johnson MD; Beauregard H; Marcovitz S; Nyomba BL; Ramirez JR; Ur E
    Clin Invest Med; 2006 Feb; 29(1):29-39. PubMed ID: 16553361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.
    Baroni MG; Giorgino F; Pezzino V; Scaroni C; Avogaro A; ;
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):85-102. PubMed ID: 26905474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent consensus statements in pediatric endocrinology: a selective review.
    Klein M; Sathasivam A; Novoa Y; Rapaport R
    Endocrinol Metab Clin North Am; 2009 Dec; 38(4):811-25. PubMed ID: 19944294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acromegaly: an endocrine society clinical practice guideline.
    Katznelson L; Laws ER; Melmed S; Molitch ME; Murad MH; Utz A; Wass JA;
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3933-51. PubMed ID: 25356808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrinology and oncology: closer ties will be mutually beneficial.
    Larsen PR
    Nat Clin Pract Endocrinol Metab; 2008 Nov; 4(11):585. PubMed ID: 18946487
    [No Abstract]   [Full Text] [Related]  

  • 34. Subclinical Cushing's syndrome: definition and management.
    Terzolo M; Pia A; Reimondo G
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):12-8. PubMed ID: 21988204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial: acromegaly--consensus, what consensus?
    Trainer PJ
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3534-6. PubMed ID: 12161470
    [No Abstract]   [Full Text] [Related]  

  • 36. [Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center].
    Biermasz NR; Dekkers OM; Voormolen J; de Keizer RJ; Neelis KJ; Wiggers-de Bruïne FT; Smit JW; Arias AM; Romijn JA
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2565-70. PubMed ID: 19174939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pasireotide--a somatostatin analog for the potential treatment of acromegaly, neuroendocrine tumors and Cushing's disease.
    Ben-Shlomo A; Melmed S
    IDrugs; 2007 Dec; 10(12):885-95. PubMed ID: 18041687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of inferior petrosal sinus sampling in the diagnostic localization of Cushing's disease.
    Lad SP; Patil CG; Laws ER; Katznelson L
    Neurosurg Focus; 2007; 23(3):E2. PubMed ID: 17961020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly.
    Melmed S; Ho K; Klibanski A; Reichlin S; Thorner M
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3395-402. PubMed ID: 8530571
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
    Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.